Abstract
The efficacy and tolerability of aceclofenac, a new non-steroidal anti-inflammatory drug (NSAID) was compared to that of ketoprofen in a multicentre, double-blind, prospective, randomized study of 3-months duration in patients with rheumatoid arthritis. One hundred and sixty-nine patients, aged between 22 and 70 years, were included in the study. Patients were randomly assigned to two treatment groups; either aceclofenac 100 mg b.i.d. (87 patients) or ketoprofen 50 mg t.i.d. (82 patients). A placebo tablet was administered to aceclofenac-treated patients to maintain the double-blind conditions of the study. Patients were examined at 15 days and at 1,2 and 3 months. Efficacy was assessed by the following clinical parameters: Ritchie index, pain on a visual analogue scale, grip strength, morning stiffness, spontaneous morning pain, pain on movement and nocturnal pain, together with functional capacity. Efficacy was demonstrated for both drugs, with progressive improvement in the main clinical evaluation parameters until the end of the treatment period. This was particularly pronounced at 15 days in the aceclofenac group, with a rapid improvement in the Ritchie index (base-line vs 15 days: P<0.001). Laboratory analyses performed were all within the normal range for both drugs. Eleven patients in the ketoprofen group abandoned the study because of inefficacy, whilst only 4 patients discontinued the treatment for this reason in the aceclofenac group. Eleven patients in the ketoprofen group and 2 patients in the aceclofenac group withdrew from the study because of adverse events. In summary, this study demonstrated that aceclofenac, a new NSAID, is effective in the symptomatic treatment of RA with a minor number of patient withdrawals because of inefficacy and a better safety profile than ketoprofen.
Similar content being viewed by others
References
Scholer DW, Ku EC, Boettcher I, Schweizer A (1986) Pharmacology of diclofenac sodium. Am J Med 80 [Suppl 4B]:34–38
Conforti A, Donini M, Brocco D, Del Soldato P, Benoni G, Cuzzolin L (1993) Acute anti-inflammatory activity and gastrointestinal tolerability of diclofenac and nitrofac. Agents Actions 40:176–180
Grau M, Guasch J, Montero L, Felipe A, Carrasco E, Juliá S (1991) Pharmacology of the potent new nonsteroidal anti-inflammatory agent aceclofenac. Arzneimittelforschung Drug Res 41:1265–1276
Sainz-Olalla F (1988) Analgesic activity and tolerability of aceclofenac in the treatment of odontalgia. Curr Ther Res 43: 900–902
Movilia PG (1989) Evaluation of the analgesic activity and tolerability of aceclofenac in the treatment of postepisiotomy pain. Drugs Exp Clin Res 15:47–51
Honorato J, Caballero R, Giorgiani G, Movilia PG, Tapounet R (1990) Dose analgesic response study and aceclofenac plasma levels in humans. Curr Ther Res 47:605–611
Torri G (1987) Efficacy and tolerability of aceclofenac in the treatment of gonalgia: controlled double-blind study vs diclofenac. Curr Ther Res 42:453–457
Cechettin M, Cerea P, Torri G (1988) Therapeutic efficacy of aceclofenac and diclofenac in acute knee arthroses. A study of prostaglandin E2 levels in synovial fluid and in serum. Clin Trial J 25:144–151
Díaz C, Rodriguez A, Celi C, Llobet M, Tapounet R (1988) Comparison of aceclofenac and diclofenac in osteoarthritic pain. Curr Ther Res 44:252–256
Giorgianni G, Ottaviani C, Soliano A, Campi A (1992) Efficacy and tolerability of aceclofenac vs ketoprofen in the treatment of rheumatoid arthritis. Curr Ther Res 51:1–10
Grupo Estudio Gonartrosis (1992) Eficacia y tolerancia del aceclofenaco en el tratamiento de la gonartrosis. Rev Esp Reumatol 19:142–146
Grupo Estudio Artritis Reumatoide (1992) Estudio de eficacia y tolerancia de aceclofenaco frente a ketoprofen en el tratamiento de la artritis reumatoide. Rev Esp Reumatol 19:263–268
Creamer J (1992) A comparison of the pharmacokinetics of single and repeated doses of aceclofenac in young and elderly volunteers. Br J Clin Res 3:99–107
Wassif W, Bjarnason I (1992) A comparison of the effects of aceclofenac and diclofenac on gastrointestinal blood loss. Br J Clin Res 3:109–114
Veys EM (1991) 20 years experience with ketoprofen. Scand J Rheumatol [Suppl] 90:1–44
Arone S (1989) Long term study of ketoprofen SR in elderly patients. Scand J Rheumatol [Suppl 8]:10–15
Ejstrup L, Knudsen JV, Ptersen L (1989) A randomised double-blind multicentre trial comparing tenoxicam and ketoprofen in osteoarthritis. Scand J Rheumatol [Suppl] 80:48–53
Le Loet X (1989) Safety of ketoprofen in the elderly: a prospective study on 20,000 patients. Scand J Rheumatol [Suppl] 83:21–27
Arnett FC, Edworthy SM, Bloch DA, et al. (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324
Ritchie DM, Boyle JA, McInnes JM, et al. (1968) Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med 37:393–406
Steinbrocker O, Traeger Ch, Traeger Ch, Battermann RC (1949) Therapeutic criteria in rheumatoid arthritis. JAMA 140:659–662
Wijnands M, van Riel P, van't Hof M, Gribnau F, van de Putte L (1991) Longterm treatment with nonsteroidal anti-inflammatory drugs in rheumatoid arthritis: a prospective drug survival study. J Rheumatol 18:184–187
Rodriguez LAG, Jick H (1994) Risk of upper gastrointestinal bleeding and perforation associated with individual nonsteroidal anti-inflammatory drugs. Lancet 43:769–772
Author information
Authors and Affiliations
Additional information
Preliminary results from this study have been published in Rev Esp Reumatol 1992; 19:263–268
Rights and permissions
About this article
Cite this article
Martín-Mola, E., Gijón-Baños, J. & Ansoleaga, J.J. Aceclofenac in comparison to ketoprofen in the treatment of rheumatoid arthritis. Rheumatol Int 15, 111–116 (1995). https://doi.org/10.1007/BF00302127
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00302127